0 Comments
0 Shares
204 Views
0 Reviews
Search
Discover new people, create new connections and make new friends
-
Please log in to like, share and comment!
-
How to streamline billing workflows for oncology clinics?Efficient billing workflows are critical for oncology clinics to maintain financial stability while delivering high-quality patient care. Oncology treatments involve complex procedures, expensive medications, and frequent insurance interactions, making the billing process intricate and time-consuming. Implementing strategies to streamline billing workflows can reduce errors, improve...0 Comments 0 Shares 202 Views 0 Reviews
-
Revenue Cycle for Radiation Oncology: A Specialized GuideRevenue cycle management in radiation oncology is a highly specialized process that requires precision, compliance, and deep clinical understanding. Unlike general medical billing, radiation oncology involves complex treatment plans, multiple CPT codes, staged therapies, and strict payer regulations. Effective management of this cycle ensures that providers receive timely and accurate...0 Comments 0 Shares 648 Views 0 Reviews
-
What are HCPCS codes used for oncology drug billing?HCPCS codes play a critical role in medical billing for oncology, especially when it comes to accurately reporting drugs, chemotherapy agents, and supportive medications used in cancer treatment. In oncology reimbursement, precision is essential because even small coding errors can lead to claim denials, underpayments, or compliance risks. Understanding HCPCS Codes in Oncology Billing...0 Comments 0 Shares 354 Views 0 Reviews
-
Advancing Thoracic Oncology: How Mesothelioma Cancer Treatment and Pleural Mesothelioma Therapy Are Transforming the Malignant Pleural Mesothelioma Treatment MarketThe evolution of mesothelioma cancer treatment has fundamentally transformed the approach to managing this challenging thoracic malignancy, offering patients and healthcare providers a growing arsenal of therapeutic options. Mesothelioma cancer treatment encompasses a range of approaches, including surgery, chemotherapy, radiation therapy, and immunotherapy, that are used alone or in...0 Comments 0 Shares 392 Views 0 Reviews
-
Antibody-Drug Conjugate (ADC) Oncology Market: Insights, Key Players, and Growth AnalysisAntibody-Drug Conjugate (ADC) Oncology Market Summary: According to the latest report published by Data Bridge Market Research, the Antibody-Drug Conjugate (ADC) Oncology Market CAGR Value The global Antibody-Drug Conjugate (ADC) oncology market size was valued at USD 1.28 billion in 2025 and is expected to reach USD 2.91 billion by 2033, at a CAGR of...0 Comments 0 Shares 549 Views 0 Reviews
-
Biosimilar Bevacizumab Market – Ophthalmology and Non-Oncology ExpansionMarket Overview The biosimilar bevacizumab market is expanding beyond oncology into ophthalmology, where intravitreal bevacizumab treats age-related macular degeneration, diabetic retinopathy, and retinal vein occlusion at significantly lower cost than branded anti-VEGF ophthalmic agents. Off-label ophthalmic use of systemic bevacizumab has been compounded for eye injection, and biosimilars may...0 Comments 0 Shares 196 Views 0 Reviews
-
Cachexia Treatment Therapies and Cancer-Related Muscle Wasting: Revolutionizing Oncology Supportive CareIn the realm of oncology supportive care, few areas have seen as much progress and innovation as the development of cachexia treatment therapies. The evolution of these therapies has been a game-changer, transforming what was once a neglected complication into a focus of comprehensive, multidisciplinary care. Central to this transformation are Cachexia Treatment Therapies , which...0 Comments 0 Shares 313 Views 0 Reviews
-
Cancer Immunotherapy Market Innovations in Next-Generation Immuno-OncologyThe global Cancer Immunotherapy Market was valued at USD 153.3 billion in 2025 and is projected to grow from USD 166.4 billion in 2026 to USD 305.8 billion by 2033, registering a CAGR of 9.0% from 2026 to 2033. North America dominated the global market with the largest revenue share of 43.3% in 2025, primarily driven by the increasing prevalence of cancer, continuous innovation in...0 Comments 0 Shares 1K Views 0 Reviews
-
Cell Cryopreservation Market – CAR-T Cell Banking Expanding in Immuno-OncologyMarket Overview The cell cryopreservation market is accelerating as CAR-T cell banking expands across immuno-oncology, enabling the collection, controlled-rate freezing, and long-term liquid nitrogen storage of autologous T lymphocytes before leukapheresis manufacturing or as a backup for potential future re-infusion. Cryopreserved starting material ensures that patients with aggressive...0 Comments 0 Shares 333 Views 0 Reviews
-
China Vascular Embolization Market: Application and Technique Trends, and the Growing Importance of Oncology and Coiling DevicesThe China Vascular Embolization Market is a dynamic market with diverse application and technique needs. Valued at USD 208.81 million in 2024 and projected to reach USD 590.0 million by 2035, the market is characterized by the leadership of oncology applications and coiling devices, alongside the rapid emergence of peripheral vascular disease applications and non-coiling technologies,...0 Comments 0 Shares 319 Views 0 Reviews
-
Clinical Oncology Next Generation Sequencing Market In-Depth Research Report with Industry Forecast"Global Executive Summary Clinical Oncology Next Generation Sequencing Market Market: Size, Share, and Forecast Data Bridge Market Research analyses that the clinical oncology next generation sequencing market which was USD 592.56 million in 2021, would rocket up to USD 1825.30 million by 2029, and is expected to undergo a CAGR of 15.1% during the forecast period 2022 to 2029. The complete...0 Comments 0 Shares 963 Views 0 Reviews
-
Dasatinib Market Growth in Emerging Healthcare MarketsThe global Dasatinib Market was valued at USD 5.6 billion in 2025 and is projected to reach USD 7.6 billion by 2033, expanding at a CAGR of 4.3% from 2026 to 2033. The market is witnessing steady growth due to the increasing prevalence of hematologic cancers, particularly Chronic Myeloid Leukemia (CML) and Philadelphia chromosome-positive Acute Lymphoblastic Leukemia (Ph+ ALL)....0 Comments 0 Shares 1K Views 0 Reviews
-
How to comply with state billing regulations?Compliance with state billing regulations is a critical aspect of running a successful oncology practice. With complex treatments, high-cost medications, and diverse payer requirements, ensuring adherence to legal and regulatory standards can be challenging. Leveraging professional oncology medical billing services is an effective way for practices to stay compliant while maintaining...0 Comments 0 Shares 250 Views 0 Reviews
-
Late-Stage Oncology Drug Pipeline Market Research Report: Size, Share, Growth Factors, Trends & Forecast"Detailed Analysis of Executive Summary Late-Stage Oncology Drug Pipeline Market Market Size and Share The global late-stage oncology drug pipeline market size was valued at USD 10.85 billion in 2025 and is expected to reach USD 26.67 billion by 2033, at a CAGR of 11.90% during the forecast period Late-Stage Oncology Drug Pipeline Market Market research report is a...0 Comments 0 Shares 521 Views 0 Reviews
-
Late-Stage Oncology Drug Pipeline Market Share and Size Report: Emerging Trends and Forecast Analysis" According to the latest report published by Data Bridge Market Research, the Late-Stage Oncology Drug Pipeline Market The global late-stage oncology drug pipeline market size was valued at USD 10.85 billion in 2025 and is expected to reach USD 26.67 billion by 2033, at a CAGR of 11.90% during the forecast period A large scale Late-Stage Oncology Drug...0 Comments 0 Shares 239 Views 0 Reviews
-
Late-Stage Oncology Drug Pipeline Market Size, Share, Trends, Growth & Forecast Explained"Regional Overview of Executive Summary Late-Stage Oncology Drug Pipeline Market by Size and Share The global late-stage oncology drug pipeline market size was valued at USD 10.85 billion in 2025 and is expected to reach USD 26.67 billion by 2033, at a CAGR of 11.90% during the forecast period This Late-Stage Oncology Drug Pipeline report helps you to be there on...0 Comments 0 Shares 411 Views 0 Reviews
-
Oncology Based In-Vivo Contract Research Organization (CRO) Market Size, Share and Trends Analysis Report – Industry Overview and Forecast to 2033According to the latest report published by Data Bridge Market Research, the Oncology Based In-Vivo Contract Research Organization (CRO) Market The global oncology based In-Vivo contract research organization (CRO) market size was valued at USD 1.29 billion in 2025 and is expected to reach USD 2.23 billion by 2033, at a CAGR of 7.09% during...0 Comments 0 Shares 461 Views 0 Reviews
-
Post-CDK4/6 Treatment Line Oncology Drugs Market Industry Assessment: Demand Trends and Outlook 2025–2033According to the latest report published by Data Bridge Market Research, the Post-CDK4/6 Treatment Line Oncology Drugs Market The global post-CDK4/6 treatment line oncology drugs market size was valued at USD 3.53 billion in 2025 and is expected to reach USD 10.06 billion by 2033, at a CAGR of 14.00% during the forecast period The reliable Post-CDK4/6...0 Comments 0 Shares 461 Views 0 Reviews
-
Radiation Oncology Market Insights for Investors and BusinessesThe global Radiation Oncology Market was valued at USD 14.0 billion in 2025 and is projected to grow from USD 15.5 billion in 2026 to USD 33.1 billion by 2033, registering a CAGR of 11.4% from 2026 to 2033. North America accounted for the largest revenue share of 46.2% in 2025, driven by the increasing prevalence of cancer, continuous technological advancements, and growing demand for...0 Comments 0 Shares 655 Views 0 Reviews
-
Step-by-Step Guide to Oncology Insurance Verification and Patient CoverageIn oncology practices, ensuring accurate insurance verification is crucial for smooth billing and timely patient care. Missteps in this process can lead to claim denials, delayed reimbursements, and administrative headaches. Implementing a structured approach improves efficiency and maximizes revenue. Here’s a comprehensive step-by-step guide for oncology insurance verification and...0 Comments 0 Shares 416 Views 0 Reviews
More Results